Colin Garner
Plus aucun poste en cours
Profil
Colin Garner is the founder of Pharmaron Abs, Inc. which was founded in 1997.
He also held former positions as Research Director at Biocode, Inc., Non-Executive Director at Xceleron Ltd.
from 1996 to 2013, and Professor-Molecular Epidemiology at The University of York.
Anciens postes connus de Colin Garner
| Sociétés | Poste | Fin |
|---|---|---|
Xceleron Ltd.
 Xceleron Ltd. Miscellaneous Commercial ServicesCommercial Services Xceleron Ltd. provides bioanalytical Accelerator Mass Spectrometry (AMS) services for accelerated early drug development. The company uses ultra-sensitive AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I and Phase II/III clinical trials. It was founded in 1997 and is located in York, the United Kingdom. | Directeur/Membre du Conseil | 24/01/2013 |
Pharmaron Abs, Inc.
 Pharmaron Abs, Inc. Pharmaceuticals: MajorHealth Technology Xceleron, Inc. provides drug development and biomedical research services. Its services include pharmaceutical and analytical method quality. The company was founded by Colin Garner in 1997 and is headquartered in Germantown, MD. | Fondateur | - |
Biocode, Inc.
 Biocode, Inc. Office Equipment/SuppliesProducer Manufacturing Biocode identifies counterfeit solid and liquid products using a covert method based on monoclonal antibody technology. And develops techniques to provide brand protection and identification to prevent counterfeitin | Directeur Technique/Scientifique/R&D | - |
| The University of York | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Xceleron Ltd.
Xceleron Ltd. Miscellaneous Commercial ServicesCommercial Services Xceleron Ltd. provides bioanalytical Accelerator Mass Spectrometry (AMS) services for accelerated early drug development. The company uses ultra-sensitive AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I and Phase II/III clinical trials. It was founded in 1997 and is located in York, the United Kingdom. | Commercial Services |
Biocode, Inc.
Biocode, Inc. Office Equipment/SuppliesProducer Manufacturing Biocode identifies counterfeit solid and liquid products using a covert method based on monoclonal antibody technology. And develops techniques to provide brand protection and identification to prevent counterfeitin | Producer Manufacturing |
Pharmaron Abs, Inc.
Pharmaron Abs, Inc. Pharmaceuticals: MajorHealth Technology Xceleron, Inc. provides drug development and biomedical research services. Its services include pharmaceutical and analytical method quality. The company was founded by Colin Garner in 1997 and is headquartered in Germantown, MD. | Health Technology |
